Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (1) , e97-e103
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of SEER Treatment Data With Medicare ClaimsMedical Care, 2016
- A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial CarcinomaEuropean Urology, 2014
- Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)Cancer, 2011
- Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005BJU International, 2010
- Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based StudyEuropean Urology, 2010
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma CollaborationCancer, 2009
- Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinomaInternational Journal of Urology, 2008
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tractUrology, 2006
- Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancerInternational Journal of Urology, 2004